Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
3179.00    95.00 (3.08%)
Bid:
3186.00
Ask:
3188.00
Spread: 2.00 (0.063%)
Market Cap: £4.43b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Third Quarter Trading Statement

27 Oct 2011 07:00

RNS Number : 9104Q
Croda International PLC
27 October 2011
 



27 October 2011

 

Croda International Plc

 

Third Quarter Trading Statement

 

Commenting on trading for the quarter ended 30 September 2011, Martin Flower, Chairman of Croda International Plc, said:

 

"I am pleased to report good turnover and profit progress in the third quarter, driven by sales growth and margin improvement in our core businesses.

 

For the three months ended 30 September 2011, Group sales from continuing operations increased 5.1% to £265.6m (2010: £252.6m). In most business areas we saw an improving trend during the quarter.

 

Operating profit from continuing operations increased 18.3% to £57.6m (2009: £48.7m). Interest costs fell, resulting in continuing pre-tax profit increasing 20.8% to £57.4m (2010: £47.5m).

Year-to-date, the pre-tax profit from continuing operations is up 27.1% at £182.2m (2010: £143.4m).

 

Consumer Care continued to trade strongly in the third quarter, reporting a significant increase in sales (+13.6%) and operating profit (+30.8%) and improved margins versus the corresponding quarter in 2010. Sales and operating profits in all business areas within Consumer Care were well ahead of 2010.

 

Industrial Specialities turnover declined 3.5% against the tough comparatives of a particularly strong third quarter in 2010. The shortfall was in July, with sales in the rest of the period ahead of 2010. Operating profit was down 6.8% with a decrease in commodity and by-product profitability being partially mitigated by stronger performances elsewhere in the sector.

 

Net debt reduced by £15.5m to £237.8m in the quarter (2010: £240.7m) despite completing the £50m buyback programme in the period.

 

Croda continues to trade well and we expect to report further progress in the final quarter and into 2012."

 

For further information please contact:

 

Mike Humphrey

Group Chief Executive

01405 860551

Sean Christie

Group Finance Director

01405 860551

Charlie Armitstead

FTI Consulting

020 7269 7176

 

 

The company will host a conference call for analysts at 8.00am today.

 

Please dial +44 (0)1452 562 815 and quote "Croda International" to gain access to the call.

 

Additional Information

 

 

 

 

 

£m

Q3

9 months

2011

2010

2011

2010

Consumer Care

145.6

128.2

+13.6%

439.2

392.6

+11.9%

Industrial Specialities

120.0

124.4

-3.5%

386.0

371.9

+3.8%

Continuing turnover

265.6

252.6

+5.1%

825.2

764.5

+7.9%

Consumer Care

42.5

32.5

+30.8%

130.5

103.6

+26.0%

Industrial Specialities

15.1

16.2

-6.8%

52.4

45.6

+14.9%

Continuing operating profit

57.6

48.7

+18.3%

182.9

149.2

+22.6%

Operating margin

 

21.6%

 

19.3%

 

 

 

22.2%

 

19.5%

 

 

 

Interest

(0.2)

(1.2)

(0.7)

(5.8)

Continuing pre tax profit

57.4

47.5

+20.8%

182.2

143.4

+27.1%

 

 

 

 

Analysis of Q3 turnover uplift

Price/mix

+18.4%

Volume

-14.8%

Currency translation

+1.5%

Continuing turnover increase

+5.1%

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTMFBATMBJTBIB
Date   Source Headline
11th Feb 20164:56 pmRNSHolding(s) in Company
11th Feb 20162:26 pmRNSDirector/PDMR Shareholding
9th Feb 20169:02 amRNSHolding(s) in Company
8th Feb 20169:55 amRNSHolding(s) in Company
4th Feb 20163:58 pmRNSHolding(s) in Company
18th Jan 20165:25 pmRNSHolding(s) in Company
18th Jan 20169:36 amRNSHolding(s) in Company
13th Jan 20164:47 pmRNSHolding(s) in Company
12th Jan 20162:40 pmRNSDirector/PDMR Shareholding
11th Jan 20164:28 pmRNSHolding(s) in Company
11th Dec 20152:32 pmRNSDirector/PDMR Shareholding
3rd Dec 201510:00 amRNSDirector/PDMR Shareholding
1st Dec 20157:00 amRNSAcquisition
25th Nov 20155:16 pmRNSHolding(s) in Company
23rd Nov 20151:56 pmRNSDirector/PDMR Shareholding
11th Nov 20152:44 pmRNSDirector/PDMR Shareholding
5th Nov 20157:00 amRNSTrading Update for the third quarter of 2015
3rd Nov 201510:42 amRNSDirector/PDMR Shareholding
13th Oct 20153:56 pmRNSDirector/PDMR Shareholding
30th Sep 20152:52 pmRNSDirector/PDMR Shareholding
28th Sep 20154:58 pmRNSHolding(s) in Company
21st Sep 20158:32 amRNSDirectorate Change
17th Sep 20154:20 pmRNSDirector/PDMR Shareholding
11th Sep 20152:02 pmRNSDirector/PDMR Shareholding
10th Sep 20159:01 amRNSTransaction in Own Shares
7th Sep 20159:44 amRNSHolding(s) in Company
2nd Sep 201510:49 amRNSHolding(s) in Company
20th Aug 201510:15 amRNSDirector/PDMR Shareholding
14th Aug 20158:25 amRNSDirector Declaration
11th Aug 201511:49 amRNSDirector/PDMR Shareholding
21st Jul 20157:00 amRNSInterim Results
13th Jul 201512:01 pmRNSDirector/PDMR Shareholding
15th Jun 201510:30 amRNSHolding(s) in Company
11th Jun 201512:17 pmRNSDirector/PDMR Shareholding
8th Jun 201512:02 pmRNSDirector/PDMR Shareholding
4th Jun 201510:19 amRNSDirector/PDMR Shareholding
3rd Jun 201510:26 amRNSDirector/PDMR Shareholding
2nd Jun 20152:18 pmRNSDirector/PDMR Shareholding
1st Jun 20155:03 pmRNSDirector/PDMR Shareholding
12th May 20152:28 pmRNSDirector/PDMR Shareholding
28th Apr 20154:53 pmRNSDirector/PDMR Shareholding
23rd Apr 201511:47 amRNSResult of AGM
22nd Apr 20157:00 amRNS1st Quarter Trading Update
16th Apr 20159:13 amRNSHolding(s) in Company
13th Apr 20153:56 pmRNSDirector/PDMR Shareholding
2nd Apr 201510:37 amRNSDirector Declaration
23rd Mar 20155:30 pmRNSAnnual Financial Report
20th Mar 20152:09 pmRNSDirector/PDMR Shareholding
19th Mar 20153:56 pmRNSDirector/PDMR Shareholding
11th Mar 20153:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.